Elanco Animal Health Incorporated (ELAN) Stock

Elanco Animal Health Incorporated (ELAN) is a Healthcare stock trading at $24.21 (as of 2026-06-18), with a market capitalization of $11.91B and a trailing P/E of -49.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Elanco Animal Health Incorporated develops, manufactures, and markets animal health products for companion animals and livestock. Its offerings include preventive treatments, therapeutics, and vaccines for pets, plus products for poultry, aquaculture, ruminants, and swine, sold through distributors, veterinarians, and farm animal producers.

Valuation — source: SEC EDGAR (first-party)
Price$24.21
Market Cap$11.91B
P/E Ratio-49.3
EV / EBITDA31.2
Price / Book1.86
Price / Sales2.47
DCF Value (model)$1.46
DCF Upside vs Price-94.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$4.71B
Net Margin-4.9%
Return on Equity-3.7%
Debt / Equity0.58
Current Ratio2.16
Revenue Growth (YoY)6.2%
EPS Growth (YoY)-169.1%
FCF Growth (YoY)-27.9%
Financial Health — source: SEC EDGAR
Altman Z-Score1.30 (distress)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Stock P/E-49.3
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-335.3%
vs Industry-385.8%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderDodge & Cox ($1.65B)
Institutional Holders Tracked10
Congressional Trades (recent)8
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJeffrey N. Simmons
Employees9,000
CountryUS
IPO Date2018-09-20

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Madrigal Pharmaceuticals, Inc. (MDGL)
  • Ionis Pharmaceuticals, Inc. (IONS)
  • Moderna, Inc. (MRNA)
  • Exelixis, Inc. (EXEL)
  • BioMarin Pharmaceutical Inc. (BMRN)
  • Radiopharm Theranostics Limited (RADX)
  • Jazz Pharmaceuticals plc (JAZZ)
  • Qiagen N.V. (QGEN)
ELAN earnings history · ELAN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.